Evidence map›Paper›PMID 39286855›Full record

ArticleThe Journal of international medical research2024

Primary ovarian leiomyosarcoma: a case report.

Qingli Zhang, Kexin Wang, Bin Wang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qingli ZhangDepartment of Radiology, Second Clinical College of Inner Mongolia University for Nationalities, Hulunbuir, Inner Mongolia 022150, China.ORCID 0009-0008-8359-1059
Kexin WangDepartment of Radiology, Second Clinical College of Inner Mongolia University for Nationalities, Hulunbuir, Inner Mongolia 022150, China.
Bin WangThe Second Clinical College of Medicine, Inner Mongolia University for Nationalities, No. 81 Lincheng Road, Yakeshi City, Inner Mongolia 022150, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary ovarian sarcoma is a rare malignancy, with primary ovarian leiomyosarcoma being even rarer because of the lack of smooth muscle in the ovaries. We herein report a case of primary ovarian leiomyosarcoma in a woman in her late 50s who presented with a 6-month history of abdominal pain. Imaging revealed a pelvic mass. The patient underwent surgery and was diagnosed with ovarian leiomyosarcoma. One month postoperatively, she began gemcitabine and docetaxel chemotherapy and continued this treatment for 6 months. Eight months postoperatively, however, recurrence was detected in the pelvic cavity. This case is reported with the aim of raising awareness about this rare disease.

Indexed as

LeiomyosarcomaOvarian NeoplasmsDeoxycytidineDocetaxelFemaleGemcitabineHumansMiddle AgedNeoplasm Recurrence, LocalTomography, X-Ray ComputedDeoxycytidineDocetaxelGemcitabinecase reporthistopathologyimmunohistochemistryleiomyosarcomaovarian malignancyOvary

Identifiers

PMID39286855
PMCPMC11440522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.